Book the Most Important Interventional Cardiology Meetings in 2018

March 10-12 | ACC 2018 – American College of Cardiology 

The first major annual meeting is the American College of Cardiology (ACC), to be held in Orlando on March 10 thru 12, in Orlando (Florida).

Date: March 10, 11, 12.

Venue: Orange County Convention Center.

City: Orlando, Florida, US.

More information 

 

May 22-25 | EuroPCR 2018

The global leading course in interventional cardiology will make the headlines next May, when the new edition of this renowned event takes place at Palais des Congrès (Paris).

Date: May 22-25, 2018

Venue: Palais des Congrès,

City: Paris, France.

More information 

 

August 25-29 | ESC Congress 2018

This event, which last year gathered over 30,000 healthcare professionals from 150 different countries, will be back in August to keep adding value to our specialty, with prestigious international guests, invaluable must-see scientific sessions and ample industry participation.  

 

Date: August Saturday 25 – Wednesday 29, 2018 (5 days),

City: Munich, Germany.

More information  

 

September 21-25 | TCT 2018

Once more, the Cardiovascular Research Foundation (CRF) prepares for the new edition of the Transcatheter Cardiovascular Therapeutics (TCT), one of the favorite meetings in the field of interventional cardiology. The event will be held in the city of San Diego (CA), USA, from September 21 thru 25, 2018.

Date: September 21 thru 25, 2018

Venue: San Diego Convention Center 

City: San Diego, CA, US.

More information 

 

November 10-14 | AHA 2018 Scientific Sessions

2018 scientific sessions will close the year with important scientific advances, new technology, and new studies in the field. The meeting will take place in Chicago, Illinois, US, from November 10 thru 14, 2018. The venue will be the Chicago Convention Center.

Date: November 10-14, 2018

Venue: Chicago Convention Center.

City: Chicago, Illinois, US.

More information 


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

ACC 2026: SURViV Trial Results – Exclusive Presentation and Analysis with Dr. Dimytri Siqueira

Following the presentation of the SURViV trial in the Late Breaking Clinical Trials sessions at the American College of Cardiology Congress, Dr. Dimytri Siqueira...

SOLACI Technicians Webinar – Ultrasound Pulses + Calcium = Coronary Lithotripsy

The Latin American Society of Interventional Cardiology (SOLACI) invites you to participate in a new Live SOLACI Webinar specially designed for technicians, nurses, and...

COMPLICAT 2026: Collaborative learning to address complications in congenital and structural heart disease

Free online course in Spanish5 webinars in 2026 COMPLICAT 2026 returns with its second edition, consolidating itself as an innovative academic space dedicated to the...

CHIP LATAM | Chapter 2 – Mexico: Complications Workshop

The Latin American Society of Interventional Cardiology invites the entire medical community to participate in a virtual workshop on complications organized by SOLACI’s Complex...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

ACVC 2026 | CELEBRATE Trial: Prehospital Zalunfiban Use in STEMI

Optimizing antithrombotic therapy in the prehospital phase of ST-segment elevation myocardial infarction (STEMI) remains challenging due to the delayed onset of action of P2Y12...

ACVC 2026 | BOX Substudy: Mean Arterial Pressure Targets in Cardiogenic Shock After OHCA

Hemodynamic management of cardiogenic shock following ischemic out-of-hospital cardiac arrest (OHCA-AMICS) remains an unresolved issue, particularly regarding optimal mean arterial pressure (MAP) targets and...

ACVC 2026 | FLASH Registry European Cohort: Mechanical Thrombectomy in Pulmonary Embolism

The management of intermediate-high and high-risk pulmonary embolism (PE) remains an area of therapeutic uncertainty, particularly in patients with right ventricular (RV) dysfunction, in...